0001562180-17-003867.txt : 20171213
0001562180-17-003867.hdr.sgml : 20171213
20171213195337
ACCESSION NUMBER: 0001562180-17-003867
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171211
FILED AS OF DATE: 20171213
DATE AS OF CHANGE: 20171213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lehman David Aaron
CENTRAL INDEX KEY: 0001354228
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36545
FILM NUMBER: 171254963
MAIL ADDRESS:
STREET 1: 6035 STONERIDGE DRIVE
CITY: PLEASANTON
STATE: CA
ZIP: 94588
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Intersect ENT, Inc.
CENTRAL INDEX KEY: 0001271214
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 200280837
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1555 ADAMS DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650-641-2100
MAIL ADDRESS:
STREET 1: 1555 ADAMS DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
FORMER COMPANY:
FORMER CONFORMED NAME: SINEXUS INC
DATE OF NAME CHANGE: 20031124
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2017-12-11
false
0001271214
Intersect ENT, Inc.
XENT
0001354228
Lehman David Aaron
C/O INTERSECT ENT, INC.
1555 ADAMS DRIVE
MENLO PARK
CA
94025
false
true
false
false
General Counsel
Common Stock
2017-12-11
4
M
false
36000.00
18.00
A
45000.00
D
Common Stock
2017-12-11
4
S
false
36000.00
32.75
D
9000.00
D
Stock Option (right to buy)
18.00
2017-12-11
4
M
false
36000.00
0.00
D
2026-02-21
Common Stock
36000.00
94000.00
D
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2017.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $33.00, inclusive. The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote on this Form 4.
The vesting commencement date of the option is February 22, 2016. 25% of the shares subject to the option shall vest on February 22, 2017 and 1/48th of the shares subject to the option shall vest monthly thereafter over three (3) years.
/s/ David A. Lehman
2017-12-13